Clinical trial
Boron Neutron Capture Therapy in Treating Patients With Glioblastoma Multiforme…
NCT00039572 · Beth Israel Deaconess Medical Center, Other · Completed
Key facts
| NCT number | NCT00039572 |
|---|---|
| Title | Boron Neutron Capture Therapy in Treating Patients With Glioblastoma Multiforme or Melanoma Metastatic to the Brain |
| Official title | A Phase I/II Trial For Neutron Capture Therapy In Glioblastoma Multiforme And Intracranial Melanoma |
| Lead sponsor | Beth Israel Deaconess Medical Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors, Melanoma (Skin), Metastatic Cancer |
| Intervention type | Drug |
| Interventions | boronophenylalanine-fructose complex |
| Start date | May 1, 2002 |
| Completion | Jan 1, 2005 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 26, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: